Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-16

Clinical Trial Update: Myfortic Versus Azathioprine in Systemic Lupus Erythematosus [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Myfortic (mycophenolate mofetil) to azathioprine in systemic lupus erythematosus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azathioprine (azathioprine)
  • MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: TERMINATED